MXPA03007380A - Derivados de imidazol 2-tio sustituidos y el uso de los mismos en la industria farmaceutica. - Google Patents
Derivados de imidazol 2-tio sustituidos y el uso de los mismos en la industria farmaceutica.Info
- Publication number
- MXPA03007380A MXPA03007380A MXPA03007380A MXPA03007380A MXPA03007380A MX PA03007380 A MXPA03007380 A MX PA03007380A MX PA03007380 A MXPA03007380 A MX PA03007380A MX PA03007380 A MXPA03007380 A MX PA03007380A MX PA03007380 A MXPA03007380 A MX PA03007380A
- Authority
- MX
- Mexico
- Prior art keywords
- thio
- imidazole derivatives
- substituted imidazole
- pharmaceutical industry
- action
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10107683A DE10107683A1 (de) | 2001-02-19 | 2001-02-19 | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| PCT/EP2002/001746 WO2002066458A2 (de) | 2001-02-19 | 2002-02-19 | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03007380A true MXPA03007380A (es) | 2004-03-16 |
Family
ID=7674545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03007380A MXPA03007380A (es) | 2001-02-19 | 2002-02-19 | Derivados de imidazol 2-tio sustituidos y el uso de los mismos en la industria farmaceutica. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7253191B2 (enExample) |
| EP (1) | EP1362045B1 (enExample) |
| JP (1) | JP2004521913A (enExample) |
| KR (1) | KR100642231B1 (enExample) |
| CN (1) | CN1291984C (enExample) |
| AT (1) | ATE282605T1 (enExample) |
| AU (1) | AU2002247726C1 (enExample) |
| BR (1) | BR0207254A (enExample) |
| CA (1) | CA2453078A1 (enExample) |
| CZ (1) | CZ20032224A3 (enExample) |
| DE (2) | DE10107683A1 (enExample) |
| DK (1) | DK1362045T3 (enExample) |
| ES (1) | ES2233808T3 (enExample) |
| HU (1) | HUP0303155A3 (enExample) |
| IL (1) | IL157050A0 (enExample) |
| IS (1) | IS6914A (enExample) |
| MX (1) | MXPA03007380A (enExample) |
| PL (1) | PL367397A1 (enExample) |
| PT (1) | PT1362045E (enExample) |
| RU (1) | RU2284326C2 (enExample) |
| SK (1) | SK10242003A3 (enExample) |
| WO (1) | WO2002066458A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| DE10222103A1 (de) | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| DE10256881A1 (de) * | 2002-12-05 | 2004-06-24 | Beiersdorf Ag | Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten |
| ATE425161T1 (de) | 2004-05-26 | 2009-03-15 | Janssen Pharmaceutica Nv | Mercaptoimidazole als ccr2-rezeptorantagonisten |
| EP1756089B1 (en) * | 2004-05-26 | 2008-10-22 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
| JP2008509201A (ja) * | 2004-08-11 | 2008-03-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｃｒ２受容体アンタゴニストとしてのメルカプトイミダゾール |
| RU2007135955A (ru) * | 2005-02-28 | 2009-04-10 | Меркле Гмбх (De) | 2-сульфинил-и 2-сульфонилзамещенные производные имидазола и их применение в качестве ингибиторов цитокина |
| EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
| WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| US8143294B2 (en) | 2007-12-31 | 2012-03-27 | Michael Burnet | 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| CN102249992A (zh) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | 一种制备2-氨基异烟酸的方法 |
| DE102013102069A1 (de) | 2013-03-01 | 2014-09-04 | Fsp Fluid Systems Partners Holding Ag | Proportional-Wegeventil sowie hydraulische Schaltung und hydropneumatisches Federungssystem mit einem derartigen Ventil |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
| US11795160B2 (en) | 2019-02-22 | 2023-10-24 | Insilico Medicine Ip Limited | Kinase inhibitors |
| AU2022225035A1 (en) | 2021-02-24 | 2023-08-31 | Insilico Medicine Ip Limited | Analogs for the treatment of disease |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1155580A (en) * | 1965-10-21 | 1969-06-18 | Geigy Ag J R | New Imidazole Derivatives their Production and Use |
| US4190666A (en) * | 1975-08-11 | 1980-02-26 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones |
| DK16778A (da) | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
| DE2963572D1 (en) * | 1978-04-11 | 1982-10-21 | Ciba Geigy Ag | Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions |
| DE2823197A1 (de) | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3141063A1 (de) * | 1981-10-13 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3504678A1 (de) * | 1985-02-12 | 1986-08-14 | A. Nattermann & Cie GmbH, 5000 Köln | Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung |
| US4686231A (en) | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
| JPS6440467A (en) | 1987-08-04 | 1989-02-10 | Hisamitsu Pharmaceutical Co | Novel substituted diphenylimidazole derivative |
| FR2626691B1 (fr) | 1988-02-02 | 1990-05-25 | France Etat | Multiplieur numerique generalise et filtre numerique mettant en oeuvre ce multiplieur |
| MX9203711A (es) | 1990-01-12 | 1992-07-01 | Rhone Poulenc Rorer Sa | Derivados de imidazol y composiciones farmaceuticas que los contienen. |
| IL104369A0 (en) | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
| US5364875A (en) * | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| AU7629594A (en) | 1993-07-21 | 1995-02-20 | Smithkline Beecham Corporation | Imidazoles for treating cytokine mediated disease |
| US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
| AU8757098A (en) * | 1997-06-30 | 1999-02-10 | Ortho-Mcneil Pharmaceutical, Inc. | 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| DE19842833B4 (de) | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
| DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
-
2001
- 2001-02-19 DE DE10107683A patent/DE10107683A1/de not_active Withdrawn
-
2002
- 2002-02-19 EP EP02716791A patent/EP1362045B1/de not_active Expired - Lifetime
- 2002-02-19 DK DK02716791T patent/DK1362045T3/da active
- 2002-02-19 PL PL02367397A patent/PL367397A1/xx not_active Application Discontinuation
- 2002-02-19 IL IL15705002A patent/IL157050A0/xx unknown
- 2002-02-19 SK SK1024-2003A patent/SK10242003A3/sk not_active Application Discontinuation
- 2002-02-19 WO PCT/EP2002/001746 patent/WO2002066458A2/de not_active Ceased
- 2002-02-19 DE DE50201565T patent/DE50201565D1/de not_active Expired - Lifetime
- 2002-02-19 HU HU0303155A patent/HUP0303155A3/hu unknown
- 2002-02-19 US US10/467,064 patent/US7253191B2/en not_active Expired - Fee Related
- 2002-02-19 BR BR0207254-8A patent/BR0207254A/pt not_active IP Right Cessation
- 2002-02-19 CZ CZ20032224A patent/CZ20032224A3/cs unknown
- 2002-02-19 PT PT02716791T patent/PT1362045E/pt unknown
- 2002-02-19 CN CNB028051548A patent/CN1291984C/zh not_active Expired - Fee Related
- 2002-02-19 KR KR1020037010839A patent/KR100642231B1/ko not_active Expired - Fee Related
- 2002-02-19 MX MXPA03007380A patent/MXPA03007380A/es active IP Right Grant
- 2002-02-19 ES ES02716791T patent/ES2233808T3/es not_active Expired - Lifetime
- 2002-02-19 AT AT02716791T patent/ATE282605T1/de not_active IP Right Cessation
- 2002-02-19 CA CA002453078A patent/CA2453078A1/en not_active Abandoned
- 2002-02-19 JP JP2002565973A patent/JP2004521913A/ja active Pending
- 2002-02-19 RU RU2003128068/04A patent/RU2284326C2/ru not_active IP Right Cessation
- 2002-02-19 AU AU2002247726A patent/AU2002247726C1/en not_active Ceased
-
2003
- 2003-08-15 IS IS6914A patent/IS6914A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1362045E (pt) | 2005-04-29 |
| CZ20032224A3 (en) | 2004-06-16 |
| ATE282605T1 (de) | 2004-12-15 |
| BR0207254A (pt) | 2004-02-10 |
| KR20030082940A (ko) | 2003-10-23 |
| DK1362045T3 (da) | 2005-03-29 |
| WO2002066458A3 (de) | 2002-12-12 |
| JP2004521913A (ja) | 2004-07-22 |
| HUP0303155A2 (hu) | 2003-12-29 |
| IS6914A (is) | 2003-08-15 |
| PL367397A1 (en) | 2005-02-21 |
| CA2453078A1 (en) | 2002-08-29 |
| RU2284326C2 (ru) | 2006-09-27 |
| CN1511149A (zh) | 2004-07-07 |
| AU2002247726C1 (en) | 2006-08-17 |
| SK10242003A3 (sk) | 2004-03-02 |
| DE10107683A1 (de) | 2002-08-29 |
| DE50201565D1 (de) | 2004-12-23 |
| US7253191B2 (en) | 2007-08-07 |
| US20040116416A1 (en) | 2004-06-17 |
| HK1056725A1 (en) | 2004-02-27 |
| EP1362045A2 (de) | 2003-11-19 |
| AU2002247726B2 (en) | 2006-01-19 |
| CN1291984C (zh) | 2006-12-27 |
| ES2233808T3 (es) | 2005-06-16 |
| RU2003128068A (ru) | 2005-01-27 |
| WO2002066458A2 (de) | 2002-08-29 |
| IL157050A0 (en) | 2004-02-08 |
| KR100642231B1 (ko) | 2006-11-02 |
| HUP0303155A3 (en) | 2007-08-28 |
| EP1362045B1 (de) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002066458A3 (de) | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| YU63202A (sh) | Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe | |
| WO2003016282A3 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| MXPA04012965A (es) | Inhibidores virales. | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| WO2004106293A3 (en) | Oxazolyl - and thiazolyl - purine based tricyclic compounds. | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| ZA200604410B (en) | Imidazole derivatives, processes for preparing them and their uses | |
| TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
| ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
| EA200000355A2 (ru) | Промышленные изделия | |
| WO2005056535A8 (en) | 1,2,3-triazole amide derivatives as inhibitors of cytokine production | |
| MXPA01008346A (es) | Compuestos quimicos. | |
| TW200509933A (en) | Therapeutic agents | |
| MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| ZA200708203B (en) | 2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors | |
| BR0318521A (pt) | arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados | |
| WO2004075846A3 (en) | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same | |
| WO2005011609A3 (en) | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| WO2003097633A8 (de) | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie | |
| SI1196129T1 (sl) | Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |